Mainz Biomed B.V.
MYNZ | NASDAQ
$3.59
+$0.03 (+0.84%)
At close: May 22, 2026, 12:35 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 537.08K | 893.99K | 895.48K | 529.88K | 577.35K | 493.57K |
Cost of Revenue | 763.01K | 319.11K | 385.82K | 347.73K | 399.73K | 370.48K |
Gross Profit | -225.93K | 574.88K | 509.66K | 182.15K | 177.62K | 123.09K |
Operating Income | -13.5M | -18.7M | -26.64M | -26.44M | -9.72M | -766.09K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -16.21M | -21.65M | -26.3M | -26.39M | -11.7M | -586.9K |
Net Income | -16.21M | -21.65M | -26.3M | -26.45M | -11.69M | -586.9K |
Selling & General & Admin | 8.93M | 12.77M | 17.22M | 22.81M | 9.41M | 458.37K |
Research & Development | 4.91M | 5.84M | 9.59M | 3.66M | 466.69K | 311.85K |
Other Expenses | -560.95K | 656.34K | 342.4K | -114.05K | -320.89K | 26.58K |
Operating Expenses | 13.27M | 19.27M | 27.15M | 26.36M | 9.56M | 796.8K |
Interest Expense | -373.46K | 1.08M | 809.58K | 289.32K | 339.17K | 268.79K |
Selling & Marketing Expenses | 3.82M | 4.7M | 3.8M | 4.98M | 957.52K | 110.38K |
Cost & Expenses | 14.04M | 19.59M | 27.54M | 26.97M | 10.3M | 1.17M |
Income Tax Expense | n/a | n/a | n/a | n/a | 377.12K | n/a |
Shares Outstanding (Basic) | 6M | 968.23K | 16.24M | 14.16M | 7.21M | 5.61M |
Shares Outstanding (Diluted) | 6M | 968.23K | 16.24M | 14.16M | 7.21M | 5.61M |
EPS (Basic) | -2.70 | -22.36 | -1.62 | -1.87 | -1.67 | -0.05 |
EPS (Diluted) | -2.70 | -22.36 | -1.62 | -1.87 | -1.67 | -0.05 |
EBITDA | -12.88M | -19.56M | -25.01M | -25.72M | -11.28M | -257.64K |
EBIT | -13.5M | -20.58M | -26.05M | -26.1M | -11.35M | -410.48K |
Depreciation & Amortization | 615.72K | 1.02M | 1.03M | 459.43K | 69.93K | 152.84K |
Add to Watchlist
Select watchlists to add or remove MYNZ